Founded in 2011, Covis Pharma is a private equity backed global specialty pharmaceutical company that markets therapeutic solutions in 50+ countries, for patients with life-threatening conditions and chronic illnesses. Our paramount concern is patient outcomes as we focus on improving the health of people with serious medical conditions. Apollo Global Management, with $455 billion AUM, is the private equity sponsor of Covis Pharma.